These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 17504292)

  • 1. Hazards of thrombolytic therapy for stroke: the real-world experience.
    Hurley JC
    Intern Med J; 2007 May; 37(5):348-9; author reply 349-50. PubMed ID: 17504292
    [No Abstract]   [Full Text] [Related]  

  • 2. Thrombolysis for stroke in the over 80s.
    Ford GA
    Age Ageing; 2004 Mar; 33(2):95-7. PubMed ID: 14960420
    [No Abstract]   [Full Text] [Related]  

  • 3. Thrombolytic therapy for acute ischemic stroke: risks vs benefits.
    Lindbloom EJ
    J Fam Pract; 2003 Oct; 52(10):757, 761. PubMed ID: 14529595
    [No Abstract]   [Full Text] [Related]  

  • 4. Raising awareness of orolingual angioedema as a complication of thrombolysis in acute stroke patients.
    Ottomeyer C; Hennerici MG; Szabo K
    Cerebrovasc Dis; 2009; 27(3):307-8. PubMed ID: 19208988
    [No Abstract]   [Full Text] [Related]  

  • 5. [Fatal massive hemoptysis during thrombolysis of acute ischemic stroke].
    de la Torre-Laviana FJ; Redondo L; Antunez-Infante A; Alvarez-Marquez E
    Rev Neurol; 2006 Oct 16-31; 43(8):510-1. PubMed ID: 17033985
    [No Abstract]   [Full Text] [Related]  

  • 6. Thrombolysis for stroke: policy should be based on science, and not on politics, money or fear of malpractice.
    Hoffman JR
    Emerg Med Australas; 2006 Jun; 18(3):215-8. PubMed ID: 16712529
    [No Abstract]   [Full Text] [Related]  

  • 7. Anaphylactoid reaction to recombinant tissue plasminogen activator.
    Krmpotic KR; Fernandes CM
    Eur J Emerg Med; 2007 Feb; 14(1):60-1. PubMed ID: 17198333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke.
    Wolfe T; Suarez JI; Tarr RW; Welter E; Landis D; Sunshine JL; Zaidat OO
    J Stroke Cerebrovasc Dis; 2008; 17(3):121-8. PubMed ID: 18436152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Older age does not increase risk of hemorrhagic complications after intravenous and/or intra-arterial thrombolysis for acute stroke.
    Pundik S; McWilliams-Dunnigan L; Blackham KL; Kirchner HL; Sundararajan S; Sunshine JL; Tarr RW; Selman WR; Landis DM; Suarez JI
    J Stroke Cerebrovasc Dis; 2008 Sep; 17(5):266-72. PubMed ID: 18755405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of acute ischemic apoplexy].
    Andersen G; Krieger DW; Iversen HK
    Ugeskr Laeger; 2009 Mar; 171(13):1094. PubMed ID: 19321089
    [No Abstract]   [Full Text] [Related]  

  • 11. Thrombolysis, community hospitals, and primary stroke center.
    Jeng JS
    Acta Neurol Taiwan; 2009 Mar; 18(1):1-2. PubMed ID: 19537567
    [No Abstract]   [Full Text] [Related]  

  • 12. Mystery case: an unexpected complication of IV thrombolysis for acute ischemic stroke.
    Sheth SA; Yee AH
    Neurology; 2013 Aug; 81(7):e42-3. PubMed ID: 23940024
    [No Abstract]   [Full Text] [Related]  

  • 13. Characterization of a severe hypofibrinogenemia induced by alteplase in two patients thrombolysed for stroke.
    Matrat A; De Mazancourt P; Derex L; Nighoghossian N; Ffrench P; Rousson R; Hanss M
    Thromb Res; 2013 Jan; 131(1):e45-8. PubMed ID: 23199548
    [No Abstract]   [Full Text] [Related]  

  • 14. Intravenous thrombolytic therapy for acute ischemic stroke: the experience of a community hospital.
    Hsu YC; Sung SF; Ong CT; Wu CS; Su YH
    Acta Neurol Taiwan; 2009 Mar; 18(1):14-20. PubMed ID: 19537569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do risks outweigh benefits in thrombolysis for stroke?
    Brown SG; Macdonald SP; Hankey GJ
    BMJ; 2013 Aug; 347():f5215. PubMed ID: 23990634
    [No Abstract]   [Full Text] [Related]  

  • 16. [Upper airway obstruction by angioedema following thrombolytic therapy with recombinant tissue plasminogen activator].
    García-Jiménez A; Iriarte Sotés P; Fernández González CJ; Garrote Freire A; González Tutor J
    An Med Interna; 2003 Mar; 20(3):163-4. PubMed ID: 12756909
    [No Abstract]   [Full Text] [Related]  

  • 17. Spontaneous splenic rupture after thrombolysis for ischemic stroke.
    Sirbou R; Tissier C; Bejot Y; Freysz M
    Am J Emerg Med; 2015 Mar; 33(3):478.e3-4. PubMed ID: 25440002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ischemic ictus during thrombolytic treatment in acute myocardial infarct].
    Seijo-Martínez M; Pais A; Castro del Río M; Silva-Martínez M
    Rev Neurol; 2000 Oct 16-31; 31(8):798-9. PubMed ID: 11082894
    [No Abstract]   [Full Text] [Related]  

  • 19. Thrombolytic therapy for deep vein thrombosis: potential application of plasmin.
    Marder VJ
    Thromb Res; 2009; 123 Suppl 4():S56-61. PubMed ID: 19303506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombolytic therapy in patients with submassive pulmonary embolism.
    Dalen JE
    N Engl J Med; 2003 Jan; 348(4):357-9; author reply 357-9. PubMed ID: 12542064
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.